You are here

  • Home
  • Archive
  • Volume 82, Issue 8
  • Response to: Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients’ by Liu

Citation Tools

Article menu

Download PDFPDF

Correspondence response
Response to: Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients’ by Liu

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Fritzler MJ, Trahtemberg U on behalf of the COVID-19 Longitudinal Biomarkers of Lung Injury (COLOBILI) study group
Response to: Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients’ by Liu
Annals of the Rheumatic Diseases 2023;82:e180.